AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $1K-$15K of CRISPR Therapeutics AG (CRSP) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of CRISPR Therapeutics AG (CRSP) stock worth $1K-$15K in a STOCK Act filing on Jan 15, 2021.
The trade happened on Jan 5, 2021, 10 days before it was made public.
CRSP has moved -66.2% since the trade date, from $160.62 to $54.23 (Sep 25, 2026 close).
- Traded
- Jan 5, 2021
- Disclosed
- Jan 15, 2021
- Filing delay
- 10 days
- Price since
- -66.2%
- Source
- STOCK Act disclosure
More CRSP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.